from pipeline email

i hope they spread it out and don't focus on micro parts so much, or at least as much as possible. this sounds like the right track and no time to waste.


http://www.prnewswire.com/news-relea...129462198.html
.
how about a winner takes all approach?

adding : http://www.drugs.com/clinical_trials...tism-9312.html

http://www.nature.com/nbt/journal/v2...0-772_BX1.html